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Purpose/Objective: Stereotactic body radiation therapy (SBRT) has 
emerged as an effective treatment option for hepatic metastases. We 
evaluated the intrafractional movement of liver metastases during 
SBRT using helical Tomotherapy. 
Materials and Methods: From april 2011 onwards we treated twelve 
patients with hepatic metastases with SBRT. A dose of 60 Gy in 3-6 
fractions was administered. Before the start of RT, we implanted 
three gold markers around the metastasis for setup and for movement 
visualization due to respiration. We used the Body Pro-Loktm System 
with an abdominal compression plate combined with a vacuum 
cushion for immobilization. The compression plate was placed right 
under the xyphoid to reduce liver movement. A respiratory-correlated 
4DCT was made to determine the maximum extreme positions of the 
markers during respiration. In general a radial margin of 6 mm and a 
cranial-caudal (CC) margin of 10 mm from GTV to PTV was used. The 
difference between end-inhalation (EI) and end-exhalation (EE) was 
used to adapt these margins. The tumor was delineated on a average 
CT registered with a contrast CT and a MRI. Before the delivery of 
each fraction, a pre-treatment MVCT was performed and matched 
with the planning CT. Since this MVCT is a slow scan, respiratory 
movements result in a blurred representation of the markers. We 
verified that the center of this blurred signal corresponds with the 
center of mass of the marker. After each treatment, all patients 
underwent a post-treatment MVCT. The gold markers shifts between 
the pre- and post-treatment MVCT were determined to quantify the 
intrafractional movements. 
Results: We evaluated 42 MVCT’s from twelve patients. The median 
intrafractional marker movement for all patients was 0.6 mm (range, 
0 - 2.9 mm), 1.3 mm (range, 0.1-5.8 mm) and 0.7 mm (range, 0 – 4.1 
mm) in lateral, CC and AP direction, respectively. In lateral direction 
there was one patient and in AP direction two patients who had shifts 
larger than 2mm. In CC direction six patients had a shift below 2mm. 
One patient had a CC movement of more than 4mm in each fraction. 
There was no correlation between the differences in intrafractional 
movements of the sequential fractions. All shifts where within the 
administered margins 
Conclusions: Using Tomotherapy the median intrafractional 
movements in most patients was limited. In two cases a larger 
movement was observed. In future studies we will analyze whether 
the administered margins can be reduced in individual cases based on 
this evaluation.  
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Purpose/Objective: To develop and demonstrate the first combined 
use of MV/kV triangulation and monoscopic motion estimation in a 
clinical setting to obtain unprecedented detailed time-resolved 
measurements of internal 3D motion throughout liver SBRT treatments 
on a conventional linear accelerator. 
Materials and Methods: Ten patients with implanted gold markers 
received 11 treatment courses of three-fraction SBRT on a 
conventional linear accelerator. Two pre-treatment and one post-
treatment CBCT scans were acquired during each fraction. The CBCT 
projection images were used to estimate the internal 3D marker 
motion during CBCT acquisition with 11 Hz resolution by a monoscopic 
probability-based 2D-to-3D motion estimation method. Throughout the 
treatment delivery by 5—6 conformal (10 courses) or volumetric 
modulated arc (1 course) fields, simultaneous MV portal imaging (8 
Hz) and orthogonal kV imaging (5 Hz) were applied to determine the 
3D marker motion using either MV/kV triangulation or the monoscopic 
estimation method when marker segmentation was unachievable in 
either MV or kV images. The accuracy of the monoscopic method was 
quantified by also applying monoscopic estimation as a test for all 
treatments where MV/kV triangulation was possible. All motion is 
reported as internal motion relative to the bony anatomy.  
Results: The mean 3D RMS deviation between monoscopic estimated 
positions and triangulated positions was 0.6 mm (range, 0.3—1.4 mm), 
see Table 1, column 2. Fig.1 shows an example of observed intra-
fraction motion, relative to the mean marker position (baseline) 
during the first CBCT, for a typical treatment fraction. The mean 3D 
intra-fraction motion range during the 33 fractions was 17.6 mm 
(range, 5.6—39.5 mm). The mean 3D intra-field motion range was 11.3 
mm (2.1—35.5 mm). The mean 3D intra-fractional marker 
displacement relative to the mean position during the first CBCT was 
3.4 mm (0.7—14.5 mm). In mean, the intra-fraction 3D marker 
displacements exceeded 5.0 mm in 28.7 % of the time and in 90 % of 
the time the intra-fraction displacement was within 8.8 mm (Table 1, 
columns 3—6). The intra-fraction population systematic (SD = Σ) and 
random errors (SD = σ) were: Σ = 1.2 mm, 2.5 mm, and 1.0 mm; σ = 
1.1 mm, 3.4 mm, and 1.7 mm, in the LR, CC, and AP directions, 
respectively. The risk of large intra-fraction baseline shifts correlated 
with intra-field respiratory motion range in the CC (p = 0.040) and AP 
(p = 0.006) directions. The mean intra-fraction 3D displacement 
increased weakly as a function of elapsed intra-fraction time (2.5 mm 
after 13 min. vs. 3.7 mm after 35 min, p = 0.003). 
Conclusions: Highly detailed time-resolved internal 3D motion was 
determined throughout liver SBRT using standard imaging equipment. 
Considerable intra-fraction motion was observed. The demonstrated 
methods provide a widely available approach for motion monitoring 
that, combined with motion-adaptive treatment techniques, has the 
potential to improve the accuracy of radiotherapy for moving targets. 
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Purpose/Objective: Radiotherapy for Non-Small-Cell Lung Cancer 
(NSCLC) is limited by the risk of Radiation Induced Lung Disease 
